VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice

This publication has 35 references indexed in Scilit:

• The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
  Oncogene, 2000
• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• VIP and Breast Cancer
  Annals of the New York Academy of Sciences, 1998
• Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin‐like growth factor‐I in human mammary epithelial cells
  Journal of Cellular Physiology, 1995
• Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines
  Cancer Letters, 1995
• Multiple receptors for PACAP and VIP
  Trends in Pharmacological Sciences, 1994
• Differential signal transduction by five splice variants of the PACAP receptor
  Nature, 1993
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
  Neuron, 1992
• Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels
  Peptides, 1990
• Polypeptide with Broad Biological Activity: Isolation from Small Intestine
  Science, 1970